MX349969B - Metodos de preparación de ribósido de nicotinamida y sus derivados. - Google Patents

Metodos de preparación de ribósido de nicotinamida y sus derivados.

Info

Publication number
MX349969B
MX349969B MX2016001211A MX2016001211A MX349969B MX 349969 B MX349969 B MX 349969B MX 2016001211 A MX2016001211 A MX 2016001211A MX 2016001211 A MX2016001211 A MX 2016001211A MX 349969 B MX349969 B MX 349969B
Authority
MX
Mexico
Prior art keywords
substituted
unsubstituted
derivatives
methods
nicotinamide riboside
Prior art date
Application number
MX2016001211A
Other languages
English (en)
Spanish (es)
Other versions
MX2016001211A (es
Inventor
Migaud Marie
Redpath Philip
CROSSEY Kerri
Doherty Mark
Original Assignee
Univ Belfast
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Belfast filed Critical Univ Belfast
Publication of MX2016001211A publication Critical patent/MX2016001211A/es
Publication of MX349969B publication Critical patent/MX349969B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C07H1/06—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MX2016001211A 2013-07-29 2014-07-24 Metodos de preparación de ribósido de nicotinamida y sus derivados. MX349969B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1313465.5A GB201313465D0 (en) 2013-07-29 2013-07-29 Methods of preparing nicotinamide riboside and derivatives thereof
PCT/EP2014/065971 WO2015014722A1 (en) 2013-07-29 2014-07-24 Methods of preparing nicotinamide riboside and derivatives thereof

Publications (2)

Publication Number Publication Date
MX2016001211A MX2016001211A (es) 2016-10-28
MX349969B true MX349969B (es) 2017-08-23

Family

ID=49167061

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016001211A MX349969B (es) 2013-07-29 2014-07-24 Metodos de preparación de ribósido de nicotinamida y sus derivados.

Country Status (14)

Country Link
US (6) US10000519B2 (enExample)
EP (2) EP3027635B1 (enExample)
JP (1) JP6208352B2 (enExample)
KR (2) KR102303966B1 (enExample)
CN (2) CN105636973B (enExample)
AU (4) AU2014298629B2 (enExample)
BR (1) BR112016001774B1 (enExample)
CA (2) CA3192957A1 (enExample)
ES (1) ES2652654T3 (enExample)
GB (1) GB201313465D0 (enExample)
HK (1) HK1255037A1 (enExample)
MX (1) MX349969B (enExample)
WO (1) WO2015014722A1 (enExample)
ZA (1) ZA201802315B (enExample)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201313465D0 (en) 2013-07-29 2013-09-11 Queens University Of The Belfast Methods of preparing nicotinamide riboside and derivatives thereof
RU2016149764A (ru) * 2014-06-02 2018-07-17 Глэксосмитклайн Интеллекчуал Проперти (Но.2) Лимитед Получение и применение кристаллического бета-d-никотинамида рибозида
EP3152220A1 (en) * 2014-06-06 2017-04-12 Glaxosmithkline Intellectual Property (No. 2) Limited Nicotinamide riboside analogs and pharmaceutical compositions and uses thereof
ES2908332T3 (es) * 2014-07-24 2022-04-28 Grace W R & Co Forma cristalina de cloruro de ribosilnicotinamida
ES2963057T3 (es) * 2015-03-09 2024-03-25 Grace W R & Co Forma cristalina de ribósido de nicotinamida
KR102426320B1 (ko) * 2015-03-16 2022-07-29 크로마덱스 아이엔씨. 니코틴산 리보사이드 또는 니코틴아미드 리보사이드 조성물, 이의 환원 유도체, 및 이의 용도
WO2017011788A1 (en) 2015-07-15 2017-01-19 Cornell University Syntheses, activities, and methods of use of dihydronicotinamide riboside derivatives
KR102354784B1 (ko) 2015-08-05 2022-01-25 메트로 인터내셔널 바이오테크 엘엘씨 니코틴아미드 모노뉴클레오티드 유도체 및 그 용도
GB2542881B (en) 2015-10-02 2020-01-01 Carr Andrew Crystal forms of ß-nicotinamide mononucleotide
WO2017079195A1 (en) * 2015-11-02 2017-05-11 Mitobridge, Inc. Nicotinamide riboside and nicotinamide mononucleotide derivatives for use in the treatments of mitochondrial-related diseases
US11248018B2 (en) 2016-02-23 2022-02-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Process for preparation of nicotinamide riboside (NR) and cosmetic composition comprising (NR and a phosphate-binding agent
CA3017254C (en) * 2016-03-16 2023-08-22 ChromaDex Inc. B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof
KR20190008246A (ko) 2016-04-20 2019-01-23 크로마덱스 아이엔씨. Nad+ 증가용 전구체로서 니코틴산 리보사이드 또는 니코틴아미드 리보사이트 유도체 및 이의 환원된 유도체의 용도
WO2017218580A1 (en) 2016-06-14 2017-12-21 Rejuvenation Therapeutics Corporation Synthetic methods for the preparation of nicotinamide riboside and related compounds
GB2553001A (en) * 2016-08-19 2018-02-21 The Queen's Univ Of Belfast Lactone intermediates of nicotinamide riboside and nicotinate riboside
CN120383644A (zh) 2016-11-11 2025-07-29 英国贝尔法斯特女王大学 烟酰基核苷和还原的烟酰基核苷、其改性衍生物、磷酸化的类似物、腺苷二核苷酸共轭物、以及新颖结晶形式的有效且可规模化的合成
US11071747B2 (en) 2016-11-29 2021-07-27 University Of Iowa Research Foundation Use of NAD precursors for breast enhancement
JP7136795B2 (ja) 2016-11-29 2022-09-13 ユニバーシティー オブ アイオワ リサーチ ファウンデーション 母体の健康および／または子の健康を向上させるためのｎａｄ前駆体の使用
US11286274B2 (en) 2017-06-19 2022-03-29 Mitopower Llc Nicotinamide riboside derivatives and their uses
US11629163B2 (en) * 2017-06-30 2023-04-18 Elysium Health, Inc. Methods of synthesizing nicotinamide riboside
JP2021506898A (ja) 2017-12-22 2021-02-22 エリシウム ヘルス，インコーポレーテッド ニコチンアミドリボシドクロリドの結晶形態
WO2019122084A1 (en) 2017-12-22 2019-06-27 Stemtek Therapeutics, S.L. Process for the preparation of nicotinamide riboside chloride derivatives
WO2019152416A1 (en) 2018-01-30 2019-08-08 Metro International Biotech, Llc Nicotinamide riboside analogs, pharmaceutical compositions, and uses thereof
CN110283221A (zh) * 2018-03-19 2019-09-27 药源药物化学（上海）有限公司 杂环化合物的制备和纯化方法
CN110452277A (zh) * 2018-05-07 2019-11-15 明特奇点医疗科技(成都)有限公司 一种烟酰胺核糖的制备方法
JP2021525279A (ja) * 2018-05-22 2021-09-24 ジャンプスタート ファーティリティ ピーティーワイ リミテッド 抗加齢剤としてのニコチン酸リボシドのアミノ酸塩
BR112020022985A2 (pt) * 2018-06-21 2021-02-02 Société des Produits Nestlé S.A. composições e métodos que usam um precursor de nicotinamida adenina dinucleotídeo (nad+) e pelo menos uma cetona ou um precursor de cetona
CN108774278A (zh) * 2018-09-10 2018-11-09 张洪喜 一种制备尼克酰胺核苷盐的方法
KR102060374B1 (ko) * 2018-12-14 2019-12-30 주식회사 휴메딕스 지방알코올 컨쥬게이션된 니코틴아미드 리보사이드 유도체
US11833167B2 (en) 2018-12-17 2023-12-05 Mitopower Llc Nicotinyl riboside compounds and their uses
US11939348B2 (en) 2019-03-22 2024-03-26 Metro International Biotech, Llc Compositions comprising a phosphorus derivative of nicotinamide riboside and methods for modulation of nicotinamide adenine dinucleotide
US10618927B1 (en) 2019-03-22 2020-04-14 Metro International Biotech, Llc Compositions and methods for modulation of nicotinamide adenine dinucleotide
CN119684381A (zh) 2019-07-19 2025-03-25 生物合成股份公司 烟酰胺呋喃核糖苷盐的结晶形式以及包含其的营养补充剂和药物组合物
EP4013766B1 (en) * 2019-08-14 2025-01-22 Metro International Biotech, LLC Compounds and compositions for differential modulation of nicotinamide adenine dinucleotide
CN110642897B (zh) * 2019-09-27 2021-04-06 武汉一若生物材料有限公司 一种β-烟酰胺核糖氯化物的制备方法
CN110658224B (zh) * 2019-10-15 2022-11-22 中国中医科学院中药研究所 一种氢核磁定量分析技术测定nmn绝对含量的方法
CN111153953A (zh) * 2020-01-07 2020-05-15 杭州洁汉化工有限公司 一种烟酰胺核糖氯化物的高效合成方法
CN111454311B (zh) * 2020-04-03 2021-10-19 深圳市迪克曼科技开发有限公司 烟酰胺核糖的有机酸盐及其组合物与制备方法
CN111647032B (zh) * 2020-06-29 2023-02-24 上海舒泽生物科技研究所 一种β-烟酰胺单核苷酸的合成方法
CN111848710A (zh) * 2020-08-20 2020-10-30 深圳市迪克曼科技开发有限公司 烟酰胺核糖及其还原态、盐的制备方法
ES3001124T3 (es) * 2020-09-15 2025-03-04 Nestle Sa Métodos para producir ribósido dihidronicotinamida a partir de cloruro de ribósido de nicotinamida
CN112851730B (zh) * 2021-01-08 2023-02-21 厦门瑞林药业有限公司 一种nmn中间体nr氯化物合成方法
JP2024517260A (ja) 2021-05-04 2024-04-19 ボーハン アンド カンパニー エーエス ニコチンアミドリボシドクロリド（ｎｒｃｌ）の合成プロセス
KR20240020716A (ko) 2021-05-27 2024-02-15 메트로 인터내셔널 바이오테크 엘엘씨 니코틴산 모노뉴클레오타이드 및 이의 에스터의 결정질 고체 및 제조 및 사용 방법
KR20240156408A (ko) 2022-03-04 2024-10-29 보한 앤드 컴퍼니 에이에스. 니코틴아미드-베타-리보사이드 트리아세테이트 클로라이드(NRA-Cl)로부터 1,4-디히드로니코틴아미드 리보사이드(NRH)의 합성 방법
CN116462727A (zh) * 2023-04-23 2023-07-21 安徽瑞邦生物科技有限公司 一种β-烟酰胺核糖氯化物的制备方法
WO2024259359A2 (en) * 2023-06-14 2024-12-19 ChromaDex Inc. Nicotinamide riboside and derivatives thereof in intravenous formulations and methods of use thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU681337B2 (en) 1991-10-23 1997-08-28 Cancer Research Campaign Technology Limited Bacterial nitroreductase for the reduction of CB 1954 and analogues thereof to a cytotoxic form
US6689760B1 (en) 2000-07-10 2004-02-10 Enzrel Inc. Anti-mycobacterial compositions
WO2007061798A2 (en) * 2005-11-18 2007-05-31 Cornell Research Foundation, Inc. Nicotinoyl riboside compositions and methods of use
WO2011081942A1 (en) * 2009-12-14 2011-07-07 Cornell University Activation and activators of sirt5
JP2013522171A (ja) * 2010-03-01 2013-06-13 ミレクシス， インコーポレイテッド 化合物およびその治療用途
GB201313465D0 (en) 2013-07-29 2013-09-11 Queens University Of The Belfast Methods of preparing nicotinamide riboside and derivatives thereof
EP3152220A1 (en) * 2014-06-06 2017-04-12 Glaxosmithkline Intellectual Property (No. 2) Limited Nicotinamide riboside analogs and pharmaceutical compositions and uses thereof

Also Published As

Publication number Publication date
NZ716277A (en) 2021-03-26
AU2020201254A1 (en) 2020-03-12
US20240239831A1 (en) 2024-07-18
US20200291055A1 (en) 2020-09-17
HK1255037A1 (en) 2019-08-02
BR112016001774A8 (pt) 2020-01-21
AU2014298629A1 (en) 2016-02-11
MX2016001211A (es) 2016-10-28
BR112016001774B1 (pt) 2021-06-22
KR102414886B1 (ko) 2022-07-01
US10000519B2 (en) 2018-06-19
BR112016001774A2 (pt) 2017-08-01
WO2015014722A1 (en) 2015-02-05
US12252506B2 (en) 2025-03-18
KR20210038718A (ko) 2021-04-07
US20240101588A1 (en) 2024-03-28
EP3027635B1 (en) 2017-09-20
AU2020201254B2 (en) 2022-05-26
AU2022203196B2 (en) 2023-11-23
CN108707174A (zh) 2018-10-26
US11981698B2 (en) 2024-05-14
ES2652654T3 (es) 2018-02-05
JP6208352B2 (ja) 2017-10-04
CN105636973A (zh) 2016-06-01
US20180186824A1 (en) 2018-07-05
AU2018211238A1 (en) 2018-08-16
CA2918955A1 (en) 2015-02-05
GB201313465D0 (en) 2013-09-11
US20220259250A1 (en) 2022-08-18
JP2016530248A (ja) 2016-09-29
US11584770B2 (en) 2023-02-21
KR102303966B1 (ko) 2021-09-24
ZA201802315B (en) 2023-02-22
US20160168184A1 (en) 2016-06-16
US10815262B2 (en) 2020-10-27
CN105636973B (zh) 2018-06-01
AU2014298629B2 (en) 2018-08-16
CA2918955C (en) 2023-05-09
EP3027635A1 (en) 2016-06-08
KR20160043974A (ko) 2016-04-22
CA3192957A1 (en) 2015-02-05
HK1218918A1 (en) 2017-03-17
EP3321274A1 (en) 2018-05-16
AU2022203196A1 (en) 2022-06-02

Similar Documents

Publication Publication Date Title
MX349969B (es) Metodos de preparación de ribósido de nicotinamida y sus derivados.
PH12018500343A1 (en) Heterocyclic amides as kinase inhibitors
PH12016500169A1 (en) Polymorph of syk inhibitors
PH12013501197B1 (en) Indeno-fused ring compounds
EA201890522A1 (ru) Способ получения противогрибковых соединений
NZ707389A (en) Process for preparing bile acid derivatives
MX368882B (es) Proceso para la preparacion de triazinas.
MX2014006992A (es) Disales de acido malonico y metodo para preparar dihaluros de malonilo.
PH12014501711A1 (en) Benzyl sulfonamide derivatives useful as mogat-2 inhibitors
BR112019025028A2 (pt) Método para preparar um composto.
UA111333C2 (uk) Спосіб одержання l-аргінінової солі периндроприлу
MY185367A (en) Improved process for the preparation of osimertinib (azd9291) or a salt thereof, and ?azd9291 aniline? or a salt thereof
BR112019001447A2 (pt) método de produção para composto pirazol-amida
MX385672B (es) Metodos para preparar 5,6-dihidro-6-fenilbenzo[f]isoquinolin-2-amina sustituida.
WO2016142819A3 (en) Novel process for the preparation of ranolazine
MX382762B (es) Procesos novedosos para preparacion de estimuladores de guanilato ciclasa soluble.
MX2018007980A (es) Proceso para la preparacion de 1,1,3-trioxo-1,2-benzotiazol-6-carb oxamida.
PL410423A1 (pl) 4-chloro-2-metylofenoksyoctany alkoksymetylobis(2-hydroksyetylo)metyloamoniowe,  sposób otrzymywania i zastosowanie jako środków  ochrony roślin
EA201892406A1 (ru) Способ получения гербицидных пиридинилимидазолоновых соединений
MY186396A (en) Xanthine derivative
WO2015001565A3 (en) "an improved process for the preparation of 3-aryloxy-3- phenylpropylamine and salt thereof"
UA112888U (xx) Спосіб паралельного синтезу аліфатичних оксамідів
PL407772A1 (pl) Krystaliczna forma kompleksu trihydrat chlorku [di(2-amino-5-guanidynopentano)(4,4'-dipirydylo) miedzi (II)] i sposób jej wytwarzania
PL411936A1 (pl) Ditiogermanany oraz nowy selektywny sposób otrzymywania ditiogermananów
TN2014000308A1 (en) Benzyl sulfonamide derivatives useful as mogat - 2 inhibitors

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration